Cerenis Therapeutics Holding SA announced consolidated earnings results for the year ended December 31, 2018. For the year, operating loss was €7.1 million against €6.6 million a year ago. Net loss was €6.3 million or €0.34 per share against €5.0 million or €0.27 per share a year ago. Revenue was €0.2 million.